Coinfection of SARS-CoV-2 and influenza A (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next−generation sequencing: a case report
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1224794 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Xuefei Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China. Hauptthemen laut MEDLINE: Coinfection, Influenza, Human, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The growing number of long COVID cases has drawn clinical attention to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been spreading worldwide since winter 2019. Its symptoms are not limited to fatigue and shortness of breath but also affect daily life. We report the use of metagenomic next-generation sequencing (mNGS) to detect coinfection with SARS-CoV-2 and influenza A virus in a patient with long COVID. The patient was admitted with fever, expectoration, fatigue, and shortness of breath. The PCR test was negative due to possible clearance of SARS-Cov-2 in the upper respiratory tract of patients with long COVID. Other routine microbiological tests were also negative, making the clinical diagnosis difficult. Bronchoalveolar lavage fluid (BALF) samples were tested using mNGS. The patient was diagnosed and treated promptly, recovered quickly, and continued taking azvudine after discharge; his condition was stable. This study illustrates that mNGS may be valuable for the timely diagnosis of patients with long COVID and their mixed infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China.
- Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd., Tianjin, China.
- Infection Business Unit, Novogene Co., Ltd., Beijing, China.
Zitieren
APA
Liang, X., Wang, Q., Liu, J., Ma, J., Zhang, Y., Wang, M., Yu, Y., & Wang, L. (2023). Coinfection of SARS-CoV-2 and influenza A (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next−generation sequencing: a case report. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1224794
Vancouver
Liang X, Wang Q, Liu J, Ma J, Zhang Y, Wang M, et al. Coinfection of SARS-CoV-2 and influenza A (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next−generation sequencing: a case report. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1224794
BibTeX
@article{Liang2023,
author = {Liang, Xuefei and Wang, Qiushi and Liu, Jia and Ma, Jing and Zhang, Yajuan and Wang, Meng and Yu, Yang and Wang, Linlin},
title = {Coinfection of SARS-CoV-2 and influenza A (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next−generation sequencing: a case report},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1224794}
}
EUVIMED